Sylentis, S.a.
Clinical trials sponsored by Sylentis, S.a., explained in plain language.
-
Eye drops could replace needles for wet AMD?
Disease control CompletedThis study tested three different doses of SYL1801 eye drops in 99 people with wet age-related macular degeneration (AMD). The goal was to see if the drops are safe and can improve or maintain vision. Participants used the drops for a set period, and their vision was measured aft…
Phase 2 • Sponsor: Sylentis, S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Can a daily eye drop safely treat dry eye? phase 3 trial puts tivanisiran to the test
Symptom relief CompletedResearchers are testing tivanisiran sodium eye drops in adults with dry eye disease to see if the drops are safe when used once daily for a year. About 300 participants will receive either the tivanisiran drops or a vehicle drop, which is a solution without the active ingredient.…
Phase 3 • Sponsor: Sylentis, S.A. • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC